AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
The move ties into an increasing willingness by the pharma industry to use AI to power its drug discovery and development efforts, and to reduce the time and costs involved in getting a new drug to market. A recent GlobalData report predicted that the industry's annual spend on AI will reac...
Copies of the documents filed with the SEC by Fusion may be obtained at no charge under the “Investors & Media” section of Fusion’s website at https://ir.fusionpharma.com/sec-filings. Participants in the solicitation This communication does not co...
of $4.2 billion. Total R&D spending was $3.5 billion. The corporate headquarters are in London, England, the research and development (R&D) headquarters are in Södertälje, Sweden. Major R&D centres are located on three continents in the United States, United Kingdom, Sweden, and India. ...
Sponsored by: Almac | Aptar Pharma | Bold insight | Credence MedSystems | Mitsubishi Gas Chemical | Owen Mumford | PHC Corporation | Polyplastics-Topas | Steris | Weiss-Aug | Zeon Speciality Materials | Zwick Roell | Contact Information: ...
The move ties into an increasing willingness by the pharma industry to use AI to power its drug discovery and development efforts, and to reduce the time and costs involved in getting a new drug to market. A recent GlobalData report predicted that the industry's annual spend on AI will reac...